Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001–2010

References

• Jain P, O’Brien S. Richter's transformation in chronic lymphocytic leukemia. Oncology 2012;26:1146–1152.
   PubMed Web of Science ®Google Scholar
• Redaelli A, Laskin BL, Stephens JM, et al. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care 2004;13:279–287.
   PubMed Web of Science ®Google Scholar
• Dighiero G, Maloum K, Desablens B, et al. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med 1998;338: 1506–1514.
   Google Scholar
• Zent CS, Kyasa MJ, Evans R, et al. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 2001;92:1325–1330.
   PubMed Web of Science ®Google Scholar
• Rosenquist R, Cortese D, Bhoi S, et al. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?. Leuk Lymphoma2013 Apr 30. [Epub ahead of print]
   Google Scholar
• O’Brien S, Keating MJ. Chronic lymphoid leukemias. In: Devita VT, Lawrence TS, Rosenberg SA, et al., editors. DeVita, Hellman, and Rosenberg's cancer: principles and practice of oncology. 9th ed. New York: Lipincott Williams and Williams; 2011;1973–1987.
   Google Scholar
• Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 2000;7:223–234.
   PubMed Web of Science ®Google Scholar
• Blankart CR, Koch T, Linder R, et al. Cost of illness and economic burden of chronic lymphocytic leukemia. Orphanet J Rare Dis 2013;8:32.
   PubMed Web of Science ®Google Scholar
• Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care (Engl). 2004;13:279–87.
   PubMed Web of Science ®Google Scholar
• Stephens JM, Gramegna P, Laskin B, et al. Chronic lymphocytic leukemia: economic burden and quality of life: literature review. Am J Ther 2005;12:460–466.
   PubMedGoogle Scholar
• Dighiero G, Binet JL. When and how to treat chronic lymphocytic leukemia. N Engl J Med 2000;343:1799–1801.
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
   PubMed Web of Science ®Google Scholar
• Cheson BD. Chronic lymphocytic leukemias. In: Abeloff MD, Armitage JO, Lichter AS, et al., editors. Clinical oncology. New York: Churchill Livingstone; 2000. pp 2536–2563.
   Google Scholar
• Tsimberidou AM, Keating MJ. Richter syndrome: biology, incidence, and therapeutic strategies. Cancer 2005;103:216–228.
   PubMed Web of Science ®Google Scholar
• Rubin D, Hudnall SD, Aisenberg A, et al. Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection. Mod Pathol 1994;7:91–98.
   PubMed Web of Science ®Google Scholar
• Ansell SM, Li CY, Lloyd RV, et al. Epstein-Barr virus infection in Richter's transformation. Am J Hematol 1999;60:99–104.
   PubMed Web of Science ®Google Scholar
• Espanol I, Bichler T, Ferra C, et al. Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion. Bone Marrow Transplant 2003; 31:215–218.
   PubMed Web of Science ®Google Scholar
• Foucar K, Rydell RE. Richter's syndrome in chronic lymphocytic leukemia. Cancer 1980;46:118–134.
   PubMed Web of Science ®Google Scholar
• Mason JM, Drummond MF, Bosanquet AG, et al. The DiSC assay. A cost-effective guide to treatment for chronic lymphocytic leukemia?Int J Technol Assess Health Care 1999;15:173–184.
   PubMed Web of Science ®Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2009 [Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2012. Available from: www.hcup-us.ahrq.gov/db/nation/nis/NIS_2010_INTRODUCTION.pdf
   Google Scholar
• US Bureau of Labor. Consumer price index for medical care services. December 2012 [Internet]. Available from: www.bls.gov
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co- morbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
   PubMed Web of Science ®Google Scholar
• Skrepnek GH, Olvey EL, Sahai A. Econometric approaches in evaluating costs and outcomes within pharmacoeconomic analyses. Pharm Policy Law 2012;14:105–122.
   Google Scholar
• Houchens R, Elixhauser A. Final report on calculating nationwide inpatient sample (NIS) variances,2001. HCUP methods series report #2003-2. Bethesda, MD: US Agency for Healthcare Research and Quality; 2005.
   Google Scholar
• Mauro FR, Foa R, Giannarelli D, et al. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood 1999;94:448–454.
   PubMed Web of Science ®Google Scholar
• Hyde C, Wake B, Bryan S, et al. Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. Health Technol Assess 2002;6:1–89.
   Google Scholar
• Hays K, McCartney S. Nursing care of the patient with chronic lymphocytic leukemia. Semin Oncol 1998;21:75–79.
   Google Scholar
• Tang DH, Sullivan S, Nevins R, et al. Healthcare expenditures, hospitalizations, and productivity associated with cancer in U.S. employer settings. J Occup Envir Med 2012;54:1453–1460.
   PubMed Web of Science ®Google Scholar
• Eichhorst B, Dreyling M, Robak T, et al.; ESMO Guidelines Working Group. Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011:22(Suppl. 6):vi50–vi54.
   PubMed Web of Science ®Google Scholar